Notify me when Advent Life Sciences LLP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| AURA | Aura Biosciences, Inc. | Common Stock, par value $0.00001 per share | 3.3% | $11,768,148 | 2,071,857 | Rajesh Parekh, Ph.D. | 13 Feb 2026 | ||
| AFIB | Acutus Medical, Inc. | Common Stock, par value $0.001 per share | 0% | $0 | 0 | Advent Life Sciences LLP | 09 Jul 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|